Document Type : Review Articles


1 Dept of Health Promotion & Aging, Faculty of Health, Shiraz University of Medical Sciences, Shiraz, Iran

2 RN, Infection control supervisor, Ibn-e-Sina Hospital, Shiraz, Iran, affiliated to Shiraz University of Medical Science

3 Dept. of Health Promotion Faculty of Health Shiraz University of Medical Science Shiraz, IRAN.


Background: COVID-19[1] is a new infectious disease that has been declared by WHO[2]  as a public health emergency worldwide due to its rapid spread to China and then to other parts of the world. The present study was designed to evaluate the clinical manifestations of this disease in the elderly.
Methods: We performed a systematic review on the database of the World Health Organization, CDC[3], PubMed, Google Scholar, Scopus, and lancet. All of the articles published until March 15, 2020, have been extracted from the above articles in English on coronavirus infection, disease, virology, epidemiology, clinical features, treatment, and prevention of the disease. Of the 1376 articles, 5 were selected out of recently published articles focusing on the epidemiological information of the virus, pneumonia caused by new corona virus, and the effects of the disease on different age groups, especially the elderly, and the rest were excluded from the review. The mean age of the patients, the mean age of mortality and the  underlying diseases were chosen as the criteria of data extraction.
Findings:  Based on the researchers' perceptions of the text of the articles, 342 cases were included in these 5 studies. The mean age of the patients was 58.4 and that of the diceased patients was 66.5. More than 50% of the total cases had one or more underlying diseases.
 Conclusion: Despite the involvement of various age groups in this infection, the virus is most likely to cause severe complications and fatalities in older people with underlying diseases.


1.            WHO. Novel coronavirus—China. Geneva: World Health Organization; 2020 Jan 12. Retrieved from:
2.            Song QQ, Zhao H, Fang LQ, Liu W, Zheng C, Zhang Y. [Study on assessing early epidemiological parameters of coronavirus disease epidemic in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(4):461-5. Available from: doi:10.3760/cma.j.cn112338-20200205-00069.
3.            Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-13. Available from: doi:
4.            Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054-62. Available from: doi:
5.            Yang X, Yu Y, Xu J, Shu H, Xia Ja, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020. Available from: doi:
6.            Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A Retrospective Observational Study. 2020. Available from:
7.            Duan Q, Guo G, Ren Y, Shang H, Du J, Li M, et al. Treatment Outcomes, Influence Factors of 116 Hospitalized COVID-19 Patients with Longer/Prolonged Treatment Course in Wuhan, China. Influence Factors of. 2020;116. Available from: doi:
8.            Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382(13):1199-207. Available from: doi:10.1056/NEJMoa2001316.
9.            Ahmad T, Khan M, Haroon, Musa TH, Nasir S, Hui J, et al. COVID-19: Zoonotic aspects. Travel Medicine and Infectious Disease. 2020:101607. Available from: doi:
10.          Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565-74. Available from: doi:
11.          Zhang Q, Pan J, Zhao M-x, Lu Y-q. Clinical value of the emergency department in screening and diagnosis of COVID-19 in China. J Zhejiang Univ Sci B. 2020:1-6. Available from: doi:10.1631/jzus.B2010011.
12.          Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. Journal of Infection. 2020. Available from: doi:
13.          Li J-Y, You Z, Wang Q, Zhou Z-J, Qiu Y, Luo R, et al. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes and Infection. 2020;22(2):80-5. Available from: doi:
14.          Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv. 2020:2020.02.06.20020974. Available from: doi:10.1101/2020.02.06.20020974.
15.          Huang LL, Shen SP, Yu P, Wei YY. [Dynamic basic reproduction number based evaluation for current prevention and control of COVID-19 outbreak in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(4):466-9. Available from: doi:10.3760/cma.j.cn112338-20200209-00080.
16.          Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al. Characteristics of COVID-19 infection in Beijing. Journal of Infection. 2020;80(4):401-6. Available from: doi:
17.          Cheng JL, Huang C, Zhang GJ, Liu DW, Li P, Lu CY, et al. [Epidemiological characteristics of novel coronavirus pneumonia in Henan]. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(0):E027. Available from: doi:10.3760/cma.j.cn112147-20200222-00148.
18.          Zumla A, Niederman MS. The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security. Curr Opin Pulm Med. 2020. Available from: doi:10.1097/mcp.0000000000000676.
19.          Huang Y, Tu M, Wang S, Chen S, Zhou W, Chen D, et al. Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis. Travel Med Infect Dis. 2020:101606. Available from: doi:10.1016/j.tmaid.2020.101606.
20.          Zhou L, Liu K, Liu HG. [Cause analysis and treatment strategies of "recurrence" with novel coronavirus pneumonia (covid-19) patients after discharge from hospital]. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(0):E028. Available from: doi:10.3760/cma.j.cn112147-20200229-00219.
21.          Xu Y-H, Dong J-H, An W-M, Lv X-Y, Yin X-P, Zhang J-Z, et al. Clinical and computed tomographic imaging features of novel coronavirus pneumonia caused by SARS-CoV-2. Journal of Infection. 2020;80(4):394-400. Available from: doi:
22.          Zhu X, Yuan W, Huang K, Wang Q, Yao S, Lu W, et al. Clinical Features and Short-Term Outcomes of 114 Elderly Patients with COVID-19 in Wuhan, China: A Single-Center, Retrospective, Observational Study. China: A Single-Center, Retrospective, Observational Study (3/2/2020). 2020. Available from: doi:
23.          Al-Tawfiq JA. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19). Travel Med Infect Dis. 2020:101608. Available from: doi:10.1016/j.tmaid.2020.101608.
24.          Dai WC, Zhang HW, Yu J, Xu HJ, Chen H, Luo SP, et al. CT Imaging and Differential Diagnosis of COVID-19. Can Assoc Radiol J. 2020:846537120913033. Available from: doi:10.1177/0846537120913033.
25.          Xiong Y, Sun D, Liu Y, Fan Y, Zhao L, Li X, et al. Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes. Invest Radiol. 2020. Available from: doi:10.1097/rli.0000000000000674.
26.          Zhou S, Wang Y, Zhu T, Xia L. CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China. AJR Am J Roentgenol. 2020:1-8. Available from: doi:10.2214/ajr.20.22975.
27.          Albarello F, Pianura E, Di Stefano F, Cristofaro M, Petrone A, Marchioni L, et al. 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation. International Journal of Infectious Diseases. 2020;93:192-7. Available from: doi:
28.          Liu W, Zhu HL, Duan Y. Effective Chemicals against Novel Coronavirus (COVID-19) in China. Curr Top Med Chem. 2020;20. Available from: doi:10.2174/1568026620999200305145032.
29.          Shanmugaraj B, Siriwattananon K, Wangkanont K, Phoolcharoen W. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pac J Allergy Immunol. 2020;38(1):10-8. Available from: doi:10.12932/ap-200220-0773.
30.          Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery. 2020;76:71-6. Available from: doi:
31.          Gallego V, Nishiura H, Sah R, Rodriguez-Morales AJ. The COVID-19 outbreak and implications for the Tokyo 2020 Summer Olympic Games. Travel Medicine and Infectious Disease. 2020:101604. Available from: doi:
32.          Chen Y, Pradhan S, Xue S. What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus? Journal of the American Academy of Dermatology. 2020;82(4):1034. Available from: doi:10.1016/j.jaad.2020.02.030.